Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02514474
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.78 | |
DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A | 1DAG | 0.71 | |
DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A | 1DAF | 0.71 | |
DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A,B,C,D | 3FMF | 0.71 | |
DSD | 7-(CARBOXYAMINO)-8-AMINO-NONANOIC ACID | A | 1DAI | 0.71 | |
RGS | 4N-MALONYL-CYSTEINYL-2,4-DIAMINOBUTYRATE DISULFIDE | A | 4GR1 | 0.73 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHA | 0.76 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHB | 0.76 | |
CLH | 2-AMINO-6-[2-(2-OXO-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.75 | |
MCL | NZ-(1-CARBOXYETHYL)-LYSINE | A,B | 1O5K | 0.71 | |
MCL | NZ-(1-CARBOXYETHYL)-LYSINE | A,B | 3CPR | 0.71 | |
MCL | NZ-(1-CARBOXYETHYL)-LYSINE | A,B | 2VC6 | 0.71 | |
RO4 | [[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL- BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER | A | 2TCL | 0.7 | |
TS5 | GLUTATHIONYLSPERMIDINE | A | 1I5G | 0.71 | |
2Z9 | N-acetyl-L-alpha-aspartyl-L-alpha- glutamyl-N-[(1R)-2-carboxy-1-formylethyl]- L-valinamide | A,B | 3H1P | 0.79 | |
HCG | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-GLYCINE | A | 1W03 | 0.7 | |
HCG | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-GLYCINE | A | 1W04 | 0.7 | |
U17 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXYHEPTANOYL]- L-SERYL-L-LEUCINATE | A | 2GGB | 0.7 | |
VB1 | N^6^-[(1R)-2-{[(1S)-1-carboxypropyl]amino}- 2-oxo-1-(sulfanylmethyl)ethyl]- 6-oxo-L-lysine | A | 2VBP | 0.72 | |
W05 | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-D-ALANINE | A | 1W05 | 0.72 | |
W05 | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-D-ALANINE | A | 1W06 | 0.72 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B | 2J9P | 0.74 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B,C,D | 2VGK | 0.74 | |
LBY | N~6~-(TERT-BUTOXYCARBONYL)-L-LYSINE | A | 2ZIN | 0.7 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 3EDZ | 0.71 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 3EWJ | 0.71 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 2DDF | 0.71 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B,C,D | 2I47 | 0.71 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,C,E,I | 1BKC | 0.71 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 2FV9 | 0.71 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 3E8R | 0.71 | |
MEN | N-METHYL ASPARAGINE | A,B,K,L | 1B8D | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R, S,T,U,V,W,X | 1GH0 | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D | 1XF6 | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, H,I,J,K,L,M | 1B33 | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B | 1I7Y | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B | 3BRP | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B | 1JBO | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B | 1ALL | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B,K,L | 1EYX | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R, S,T,U,V,W,X | 1HA7 | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D | 2VJH | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B | 1KTP | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B | 1PHN | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D | 1QGW | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D | 1XG0 | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B | 2VJT | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, K,L,M,N,O,P | 2BV8 | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B | 2V8A | 0.73 | |
MEN | N-METHYL ASPARAGINE | A,B,C,D,E,F, G,H | 3DBJ | 0.73 | |
CYK | N-hexanoyl-L-homocysteine | A | 3DHC | 0.7 | |
DMH | N4,N4-DIMETHYL-ASPARAGINE | E,F,G,H | 1NKK | 0.7 | |
DMH | N4,N4-DIMETHYL-ASPARAGINE | A,B,C,D,E,F, G,H | 1NJT | 0.7 | |
DMH | N4,N4-DIMETHYL-ASPARAGINE | E,F,G,H | 1NJU | 0.7 | |
DMH | N4,N4-DIMETHYL-ASPARAGINE | Y,Z | 1JQ7 | 0.7 | |
DMH | N4,N4-DIMETHYL-ASPARAGINE | C | 1NKM | 0.7 | |
REX | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANYL-D-ALANINE | A | 1IKG | 0.78 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 2BJS | 0.71 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1QJE | 0.71 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BK0 | 0.71 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BLZ | 0.71 | |
193 | (2S)-4-(BETA-ALANYLAMINO)-2-AMINOBUTANOIC ACID | A | 1XY5 | 0.71 | |
BUJ | (3R)-3-(hexadecanoylamino)-4-(trimethylammonio)butanoate | A,B | 2RCU | 0.77 | |
SUO | N~2~-(3-CARBOXYPROPANOYL)-L-ORNITHINE | A,B,C,D | 1YNH | 0.77 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.73 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.73 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.73 | |
6PR | (S)-4-AMINO-4-OXO-3-(2-PHOSPHONOACETAMIDO)BUTANOIC ACID | A,B,C,D | 2H3E | 0.74 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.7 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.7 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.7 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.7 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.7 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.7 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.7 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.7 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.7 | |
NSK | N-SUCCINYL LYSINE | A | 2P8B | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2B4D | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD9 | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVR | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVS | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVQ | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OT7 | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2B5G | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A | 2GIV | 0.75 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNY | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A | 1JSP | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B,I,L | 2V5W | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,D | 3D4B | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OQ6 | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R0Y | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A | 3CZ7 | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A | 1JM4 | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H4H | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2J6V | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R10 | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1YC5 | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OX0 | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2G | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,D | 2H4F | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A | 2OU2 | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1S5P | 0.75 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNW | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A | 3D35 | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD2 | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A | 2ZFN | 0.75 | |
ALY | N(6)-ACETYLLYSINE | C,D | 2C1J | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQG | 0.75 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNX | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1MA3 | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2H | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A | 2I2Z | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD7 | 0.75 | |
ALY | N(6)-ACETYLLYSINE | P | 1E6I | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZC | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D,I,J, K,L | 3EWF | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2D | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1Q1A | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZD | 0.75 | |
ALY | N(6)-ACETYLLYSINE | Q,R | 2E3K | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A | 2OZU | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQF | 0.75 | |
ALY | N(6)-ACETYLLYSINE | A,B,C | 2R0V | 0.75 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G65 | 0.76 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G6A | 0.76 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G68 | 0.76 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | C,D,E,X,Y,Z | 2FG7 | 0.76 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | A | 2G6C | 0.76 | |
SN0 | N-(3-CARBOXYPROPANOYL)-L-NORVALINE | C,D,E,X,Y,Z | 2FG6 | 0.76 | |
L2A | (2S,5S,8S,11S,15E,20S)-20-amino- 2-(carboxymethyl)-11,20-dimethyl- 5,8-bis(2-methylpropyl)-3,6,9,21- tetraoxo-1,4,7,10-tetraazacyclohenicos- 15-ene-11-carboxylic acid | B | 2K1C | 0.76 | |
DLS | DI-ACETYL-LYSINE | A,B,C,D,E,F | 1FVM | 0.77 | |
O12 | N~5~-dodecanoyl-L-ornithine | A,B,C,D,E,F, G,H,I,J,K,L | 3CAY | 0.71 | |
O12 | N~5~-dodecanoyl-L-ornithine | A,B,C,D,E,F, G,H,I,J,K,L | 3CBA | 0.71 | |
CLG | 2-AMINO-6-[2-(2-AMINOOXY-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.74 | |
FEB | N~2~-[(3R)-3-hydroxydodecanoyl]- L-asparaginyl-N~1~-[(1S)-1-(hydroxymethyl)- 3-methylbutyl]-L-glutamamide | 2,H,K,N,V,Y | 3D29 | 0.7 | |
REY | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANINE | A | 1IKI | 0.76 |